Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;175(3):455-456.
doi: 10.7326/L21-0598. Epub 2022 Jan 11.

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard  1 , Olivier Thaunat  2 , Ilies Benotmane  1 , Christophe Masset  3 , Gilles Blancho  3
Affiliations

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard et al. Ann Intern Med. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0598.

Figures

Figure.
Figure.. Antispike IgG titers measured 2–6 wk after the third and fourth vaccine doses in 92 kidney transplant recipients.
Titers are expressed in BAU after calibration to the World Health Organization standard. The dotted line indicates the threshold of 143 BAU/mL. BAU = binding antibody units; D3 = third dose; D4 = fourth dose.
See this image and copyright information in PMC

References

    1. Boyarsky BJ , Werbel WA , Avery RK , et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204-2206. [PMID: ] doi:10.1001/jama.2021.7489 - DOI - PMC - PubMed
    1. Benotmane I , Gautier G , Perrin P , et al. Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses. JAMA. 2021. [PMID: ] doi:10.1001/jama.2021.12339 - DOI - PMC - PubMed
    1. Kamar N , Abravanel F , Marion O , et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients [Letter]. N Engl J Med. 2021;385:661-662. [PMID: ] doi:10.1056/NEJMc2108861 - DOI - PMC - PubMed
    1. Planas D , Veyer D , Baidaliuk A , et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596:276-280. [PMID: ] doi:10.1038/s41586-021-03777-9 - DOI - PubMed
    1. O'Brien MP , Forleo-Neto E , Musser BJ , et al; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184-1195. [PMID: ] doi:10.1056/NEJMoa2109682 - DOI - PMC - PubMed